Lonza : Two Cell and Gene Therapies Manufactured at Lonza Houston Reach US FDA Approval in Q3 2022
Basel, Switzerland, Thursday 6 October 2022 - Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutrition industries, today announced that two additional cell... | October 6, 2022
Source: marketscreener.com